Table 1C.
CLFB-1134 Chronic Dosing Pharmacokinetic Properties in Sprague-Dawley Rats.
| 7 Day Day |
Male Plasma (ng/mL) |
10 mg/kg Brain (ng/g) |
B/P | 20 mg /kg Plasma (ng/mL) |
Brain (ng/g) | B/P |
|---|---|---|---|---|---|---|
| 1 | 714 | 881 | 1.2 | 1496 | 1695 | 1.1 |
| 7 | 255 | 446 | 1.7 | 453 | 543 | 1.2 |
| % of Day 1 | 35% | 51% | 30% | 32% | ||
| 7 Day Day |
Female Plasma (ng/mL) |
10 mg/kg Brain (ng/g) |
B/P | 20 mg /kg Plasma (ng/ mL) |
Brain (ng /g) | B/P |
|---|---|---|---|---|---|---|
| 1 | 240 | 494 | 2.0 | 1051 | 640 | 0.61 |
| 7 | 104 | 157 | 1.5 | 234 | 441 | 1.9 |
| % of Day 1 | 43% | 31% | 22% | 68% | ||
| 35 Day Day |
Male Plasma (ng/mL) |
20** mg/kg Brain (ng/g) |
B/P |
|---|---|---|---|
| 1 | 1496 | 1695 | 1.2 |
| 35 | 292** | 359** | 1.2 |
| % of Day 1 | 20%** | 21%** |